» Articles » PMID: 14709241

Two Percent of HIV-positive U.S. Blood Donors Are Infected with Non-subtype B Strains

Overview
Publisher Mary Ann Liebert
Date 2004 Jan 8
PMID 14709241
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

To estimate the prevalence of HIV strains other than the predominant HIV-1B subtype in the U.S. blood donor population we genetically and serologically characterized HIV in infected blood donations collected throughout he United States from 1997 to mid-2000. Using a combination of DNA heteroduplex mobility and DNA sequence analyses of the env and gag regions of HIV-1 we determined that 285 of 312 infections were caused by HIV-1B and six by non-subtype B HIV-1 (four HIV-1C, one HIV-1AE, one HIV-1A). Genetic distances of greater than 14% in the envelope V3-V5 region of the four HIV-1C strains indicated that they did not share a recent common origin. HIV-1 group M, N, and O, and HIV-2 specific peptide serological testing of the 20 PCR-negative samples determined that one infection was caused by HIV-2 and none by HIV-1 group N and O. The major risk factor for infection with a non-HIV-1B strain was sex with an HIV-infected person from Africa although three of seven non-HIV-1B-infected subjects did not fit that category. For four of seven non-HIV-1B-infected subjects the subtype detected was consistent with the African country of origin of the infected person or of their sexual partner. The frequency of genetically confirmed non-subtype-B HIV infection in a geographically dispersed group of infected U.S. blood donors in 1977-2000 was therefore 2.0% (6/312).

Citing Articles

HIV Subtypes and Drug-resistance-associated Mutations in US Blood Donors, 2015-2020.

Custer B, Altan E, Montalvo L, Coyne A, Grebe E, Deng X Open Forum Infect Dis. 2024; 11(7):ofae343.

PMID: 38994445 PMC: 11237352. DOI: 10.1093/ofid/ofae343.


Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors.

Delwart E, Slikas E, Stramer S, Kamel H, Kessler D, Krysztof D J Infect Dis. 2012; 205(6):875-85.

PMID: 22293432 PMC: 3282564. DOI: 10.1093/infdis/jir862.


Seroconverting blood donors as a resource for characterising and optimising recent infection testing algorithms for incidence estimation.

Kassanjee R, Welte A, McWalter T, Keating S, Vermeulen M, Stramer S PLoS One. 2011; 6(6):e20027.

PMID: 21694760 PMC: 3111407. DOI: 10.1371/journal.pone.0020027.


The quasispecies nature and biological implications of the hepatitis C virus.

Fishman S, Branch A Infect Genet Evol. 2009; 9(6):1158-67.

PMID: 19666142 PMC: 2790008. DOI: 10.1016/j.meegid.2009.07.011.


HIV-2 diagnosis and quantification in high-risk patients.

Chan P, Wakeman S, Flanigan T, Cu-Uvin S, Kojic E, Kantor R AIDS Res Ther. 2008; 5:18.

PMID: 18700986 PMC: 2529329. DOI: 10.1186/1742-6405-5-18.